We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

149 hedge funds and large institutions have $227M invested in Bionano Genomics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 32

68% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $8.53M

1% more funds holding

Funds holding: 147 → 149 (+2)

8% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 26

0% more ownership

Funds ownership: 0.04% → 0.04% (+0%)

43% less capital invested

Capital invested by funds: $398M → $227M (-$171M)

Holders
149
Holders Change
+2
Holders Change %
+1.36%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
60
Reduced
32
Closed
26
Calls
$14.3M
Puts
$8.53M
Net Calls
+$5.79M
Net Calls Change
-$14.1M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$14.3M
2
Morgan Stanley
Morgan Stanley
New York
+$3.87M
3
Principal Financial Group
Principal Financial Group
Iowa
+$3.58M
4
Millennium Management
Millennium Management
New York
+$2.67M
5
EGM
Engineers Gate Manager
New York
+$2.64M

Top Sellers

Rank Fund Capital Flow
1
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
-$9.93M
2
N
Nuveen
North Carolina
-$5.35M
3
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.9M
4
PVI
Pura Vida Investments
New York
-$2.75M
5
WG
Winton Group
United Kingdom
-$2.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
QC
101
QCM Cayman
Texas
$54K +$16K +6 +25%
BBVA
102
Banco Bilbao Vizcaya Argentaria
Spain
$53K – – –
JWCA
103
J.W. Cole Advisors
Florida
$52K -$21.4K -8 -22%
BJL
104
Brighton Jones LLC
Washington
$52K – – –
VAM
105
Verity Asset Management
North Carolina
$51K +$74.9K +28 New
Balyasny Asset Management
106
Balyasny Asset Management
Illinois
$51K +$77.6K +29 New
SAM
107
Shell Asset Management
Netherlands
$50K – – –
Mackenzie Financial
108
Mackenzie Financial
Ontario, Canada
$46K -$5.35K -2 -7%
X
109
Xponance
Pennsylvania
$41K +$2.67K +1 +5%
Rafferty Asset Management
110
Rafferty Asset Management
New York
$41K +$61.5K +23 New
Credit Agricole
111
Credit Agricole
France
$40K – – –
CFGS
112
Concourse Financial Group Securities
Alabama
$39K – – –
PAG
113
Private Advisor Group
New Jersey
$38K – – –
CIBC Asset Management
114
CIBC Asset Management
Ontario, Canada
$38K +$5.35K +2 +11%
BMC
115
Benin Management Corp
Connecticut
$36K – – –
GSEP
116
Golden State Equity Partners
California
$36K +$53.5K +20 New
OSAM
117
O'Shaughnessy Asset Management
Connecticut
$31K – – –
CI
118
CPR Investments
Michigan
$31K +$45.5K +17 New
HF
119
HRT Financial
New York
$31K +$45.5K +17 New
CAM
120
Carret Asset Management
New York
$30K -$16K -6 -26%
BFAG
121
Blackston Financial Advisory Group
Florida
$30K +$45.5K +17 New
RFM
122
Royal Fund Management
Florida
$29K +$45.5K +17 New
TRCT
123
Tower Research Capital (TRC)
New York
$28K -$115K -43 -74%
CG
124
Cutler Group
California
$17K +$2.67K +1 +11%
Macquarie Group
125
Macquarie Group
Australia
$15K – – –
3 4
5
6 7

BNGO Hedge Fund Activity: Q4 2021 in Review

149 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2021, worth a combined $227M — down 43% from $398M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BNGO positions and 26 closed out — a net gain of 2 holders — while 60 added to existing stakes and 32 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $14.3M. The largest seller was Bank Julius Baer & Co, cutting an estimated $9.93M.

  • 149 institutional investors held Bionano Genomics (BNGO) as of Q4 2021, up from 147 in Q3 2021.
  • Funds reported $227M of Bionano Genomics stock for Q4 2021, down 43% quarter-over-quarter.
  • 28 funds opened new Bionano Genomics positions in Q4 2021 and 26 closed out, a net change of +2 holders.
  • The largest Bionano Genomics buyer in Q4 2021 was Citadel Advisors, an estimated $14.3M added.
  • The largest Bionano Genomics seller in Q4 2021 was Bank Julius Baer & Co, an estimated $9.93M sold.

Based on aggregated 13F filings for Q4 2021.